Tapewire

Nasdaq · USD

MLYS

Mineralys Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4432
SEC CIK
0001933414
Parsed reports
176

Last 12 months

Inside the activity.

2 purchase rows · 80 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025023
Dec 202500
Jan 2026011
Feb 202607
Mar 2026210
Apr 202605
May 202604
Jun 202608
Jul 202606
Aug 202602
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 13, 2025 Filed Nov 14, 2025 00:01 UTC SaleCommon Stock 4,885 $46.36 $226,446.13
Disclosure

SEC source: 0001933414-25-000150 · wk-form4_1763078481.xml · nonDerivative · entry 3

Karydas Daphne · CIK 0001816952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.19 to $46.70. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
November 13, 2025 Filed Nov 14, 2025 00:01 UTC SaleCommon Stock 10,115 $45.81 $463,350.95
Disclosure

SEC source: 0001933414-25-000150 · wk-form4_1763078481.xml · nonDerivative · entry 2

Karydas Daphne · CIK 0001816952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,885

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.19 to $46.18. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Read SEC document
November 13, 2025 Filed Nov 14, 2025 00:01 UTC Exercise / conversionCommon Stock 15,000 $10.20 $153,000.00
Disclosure

SEC source: 0001933414-25-000150 · wk-form4_1763078481.xml · nonDerivative · entry 1

Karydas Daphne · CIK 0001816952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 19:01 UTC Exercise / conversionStock Option · Derivative 6,933 $0.00 Strike: $10.20 $0.00
Disclosure

SEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · derivative · entry 11

Gold Alexander M · CIK 0002026429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,967

Underlying: Common Stock · 6,933 shares

Expires 2035-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option vests in 12 monthly installments following the date of grant.

Read SEC document
November 12, 2025 Filed Nov 13, 2025 19:01 UTC SaleCommon Stock 1,933 $47.28 $91,385.67
Disclosure

SEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 6

Gold Alexander M · CIK 0002026429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
November 12, 2025 Filed Nov 13, 2025 19:01 UTC SaleCommon Stock 5,000 $46.50 $232,500.00
Disclosure

SEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 5

Gold Alexander M · CIK 0002026429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,933

Read SEC document
November 12, 2025 Filed Nov 13, 2025 19:01 UTC Exercise / conversionCommon Stock 6,933 $10.20 $70,716.60
Disclosure

SEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 4

Gold Alexander M · CIK 0002026429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC Exercise / conversionStock Option · Derivative 15,000 $0.00 Strike: $10.20 $0.00
Disclosure

SEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · derivative · entry 10

Gold Alexander M · CIK 0002026429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,900

Underlying: Common Stock · 15,000 shares

Expires 2035-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock option vests in 12 monthly installments following the date of grant.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC SaleCommon Stock 5,000 $47.08 $235,408.00
Disclosure

SEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 3

Gold Alexander M · CIK 0002026429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC SaleCommon Stock 10,000 $42.43 $424,298.00
Disclosure

SEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 2

Gold Alexander M · CIK 0002026429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,000

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC Exercise / conversionCommon Stock 15,000 $10.20 $153,000.00
Disclosure

SEC source: 0001933414-25-000149 · wk-form4_1763078474.xml · nonDerivative · entry 1

Gold Alexander M · CIK 0002026429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
Exercise / conversionStock Option · Derivative 6,613 $0.00 Strike: $15.44 $0.00
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · derivative · entry 17

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,888

Underlying: Common Stock · 6,613 shares

Expires 2033-03-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of common stock subject to the option on each monthly anniversary thereafter.

F15 · balance_after: Since the date of the Reporting Person's last ownership report, 8,499 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
Exercise / conversionStock Option · Derivative 44,079 $0.00 Strike: $14.25 $0.00
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · derivative · entry 16

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,592

Underlying: Common Stock · 44,079 shares

Expires 2034-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of common stock subject to the option on each monthly anniversary thereafter.

F14 · balance_after: Since the date of the Reporting Person's last ownership report, 64,329 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
Exercise / conversionStock Option · Derivative 34,414 $0.00 Strike: $16.00 $0.00
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · derivative · entry 15

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,662

Underlying: Common Stock · 34,414 shares

Expires 2033-02-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The stock option vests as to 25% of the total number of shares of common stock subject to the option on the first anniversary of the grant date, and as to 1/48th of the total number of shares of common stock subject to the option on each monthly anniversary thereafter.

F13 · balance_after: Since the date of the Reporting Person's last ownership report, 42,442 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
Exercise / conversionStock Option · Derivative 20,547 $0.00 Strike: $10.20 $0.00
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · derivative · entry 14

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,674

Underlying: Common Stock · 20,547 shares

Expires 2035-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: The stock option vests in monthly installments over a period of four years, with 1/48th of the total shares underlying the option vesting each one-month period following the date of grant.

F11 · balance_after: Since the date of the Reporting Person's last ownership report, 13,779 stock options were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 32,718 $46.88 $1,533,976.89
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 13

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,396

F9 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.4900 to $47.3600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (9) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 38,900 $45.93 $1,786,587.53
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 12

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,114

F8 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.4800 to $46.4725. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (8) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 8,456 $45.18 $382,046.31
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 11

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,014

F7 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.4700 to $45.4600. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 4,142 $43.50 $180,183.21
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 10

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,470

F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.1700 to $44.0500. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 8,485 $42.34 $359,258.29
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 9

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,612

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.1000 to $43.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 12,952 $41.65 $539,479.29
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 8

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,097

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.0550 to $42.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 1,561 $42.68 $66,622.54
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 7

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,049

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.5100 to $42.9150. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 11,295 $41.87 $472,931.82
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 6

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,610

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.4500 to $42.2800. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 1,015 $42.00 $42,630.00
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 5

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,905

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
Exercise / conversionCommon Stock 6,613 $15.44 $102,104.72
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 4

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
Exercise / conversionCommon Stock 44,079 $14.25 $628,125.75
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 3

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,307

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
Exercise / conversionCommon Stock 34,414 $16.00 $550,624.00
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 2

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2025 Filed Nov 13, 2025 19:01 UTC
Levy Adam ScottCFO and Secretary
Exercise / conversionCommon Stock 20,547 $10.20 $209,579.40
Disclosure

SEC source: 0001933414-25-000152 · wk-form4_1763078493.xml · nonDerivative · entry 1

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,814

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Since the date of the Reporting Person's last ownership report, 83,598 shares of common stock were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:01 UTC
Congleton JonDirector · Chief Executive Officer
SaleCommon Stock 32,850 $46.89 $1,540,211.67
Disclosure

SEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 6

Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 631,305

F6 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $46.4400 to $47.4191. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:01 UTC
Congleton JonDirector · Chief Executive Officer
SaleCommon Stock 112,275 $45.83 $5,145,956.21
Disclosure

SEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 5

Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 664,155

F5 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $45.4300 to $46.4200. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:01 UTC
Congleton JonDirector · Chief Executive Officer
SaleCommon Stock 29,207 $45.20 $1,320,165.16
Disclosure

SEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 4

Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 776,430

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.4800 to $45.4297. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:01 UTC
Congleton JonDirector · Chief Executive Officer
SaleCommon Stock 4,000 $43.50 $173,983.60
Disclosure

SEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 3

Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 805,637

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.1700 to $44.0500. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:01 UTC
Congleton JonDirector · Chief Executive Officer
SaleCommon Stock 8,862 $42.31 $374,946.79
Disclosure

SEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 2

Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 809,637

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.0500 to $43.0400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
November 11, 2025 Filed Nov 14, 2025 00:01 UTC
Congleton JonDirector · Chief Executive Officer
SaleCommon Stock 12,806 $41.64 $533,235.44
Disclosure

SEC source: 0001933414-25-000151 · wk-form4_1763078487.xml · nonDerivative · entry 1

Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 818,499

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.0500 to $42.0000. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Read SEC document
October 15, 2025 Filed Oct 15, 2025 23:04 UTC
Rodman David MalcomChief Medical Officer
SaleCommon Stock 10,369 $43.01 $445,982.10
Disclosure

SEC source: 0001933414-25-000128 · wk-form4_1760569464.xml · nonDerivative · entry 1

Rodman David Malcom · CIK 0001672659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,155

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.8000 to $43.1950. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 19:04 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 3,392 $42.26 $143,332.69
Disclosure

SEC source: 0001933414-25-000130 · wk-form4_1760569476.xml · nonDerivative · entry 2

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,865

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023.

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.1600 to $42.3400. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 19:04 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 7,366 $41.90 $308,650.87
Disclosure

SEC source: 0001933414-25-000130 · wk-form4_1760569476.xml · nonDerivative · entry 1

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,257

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.1362 to $42.1300. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

F3 · balance_after: Since the date of the Reporting Person's last ownership report, 5,311 shares of common stock were transferred to an ex-spouse pursuant to a domestic relations order. The Reporting Person no longer reports as beneficially owned any securities owned by his ex-spouse.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 23:04 UTC
Congleton JonDirector · Chief Executive Officer
SaleCommon Stock 1,552 $43.03 $66,782.40
Disclosure

SEC source: 0001933414-25-000129 · wk-form4_1760569470.xml · nonDerivative · entry 2

Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 831,305

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.9822 to $43.2030. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
October 13, 2025 Filed Oct 15, 2025 23:04 UTC
Congleton JonDirector · Chief Executive Officer
SaleCommon Stock 13,548 $42.63 $577,544.47
Disclosure

SEC source: 0001933414-25-000129 · wk-form4_1760569470.xml · nonDerivative · entry 1

Congleton Jon · CIK 0001644975 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 832,857

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2024.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $41.9800 to $42.9800. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
September 15, 2025 Filed Sep 16, 2025 22:54 UTC
Rodman David MalcomChief Medical Officer
SaleCommon Stock 2,065 $36.47 $75,320.46
Disclosure

SEC source: 0001672659-25-000006 · wk-form4_1758063276.xml · nonDerivative · entry 2

Rodman David Malcom · CIK 0001672659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,524

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024.

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $36.4026 to $36.7005. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
September 15, 2025 Filed Sep 16, 2025 22:54 UTC
Rodman David MalcomChief Medical Officer
SaleCommon Stock 9,302 $35.90 $333,945.52
Disclosure

SEC source: 0001672659-25-000006 · wk-form4_1758063276.xml · nonDerivative · entry 1

Rodman David Malcom · CIK 0001672659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,589

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.4000 to $36.3955. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
September 04, 2025 Filed Sep 9, 2025 00:07 UTC PurchaseCommon Stock 588,235 $25.50 $14,999,992.50
Disclosure

SEC source: 0001415889-25-023919 · form4-09092025_120910.xml · nonDerivative · entry 1

AKKARAJU SRINIVAS · CIK 0001253170 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Samsara Opportunity Fund, L.P.

Disclosed balance after: 588,235

F1 · ownership.nature: Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opp LP"). Samsara Opportunity Fund GP, LLC ("Samsara Opp GP") is the general partner of Samsara Opp LP and may be deemed to beneficially own the securities held by Samsara Opp LP. The Reporting Person has voting and investment power over the shares held by Samsara Opp LP and, accordingly, may be deemed to beneficially own the shares held by Samsara Opp LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 21:59 UTC PurchaseCommon Stock 1,176,470 $25.50 $29,999,985.00
Disclosure

SEC source: 0001415889-25-023893 · form4-09082025_090941.xml · nonDerivative · entry 1

RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director

RA Capital Healthcare Fund LP · CIK 0001315082 · Director

RA Capital Nexus Fund III, L.P. · CIK 0001883840 · Director

Kolchinsky Peter · CIK 0001384859 · Director

Shah Rajeev M. · CIK 0001619841 · Director

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 5,456,521

F1 · ownership.nature: Held directly by the RA Capital Healthcare Fund, L.P. (the "Fund").

F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Read SEC document
August 13, 2025 Filed Aug 14, 2025 22:02 UTC
Rodman David MalcomChief Medical Officer
SaleCommon Stock 11,365 $12.93 $146,986.95
Disclosure

SEC source: 0001933414-25-000093 · wk-form4_1755208973.xml · nonDerivative · entry 2

Rodman David Malcom · CIK 0001672659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,891

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024.

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.590 to $13.223. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:02 UTC
Rodman David MalcomChief Medical Officer
Exercise / conversionStock Option · Derivative 6,349 $0.00 Strike: $1.08 $0.00
Disclosure

SEC source: 0001933414-25-000093 · wk-form4_1755208973.xml · derivative · entry 3

Rodman David Malcom · CIK 0001672659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 82,531

Underlying: Common Stock · 6,349 shares

Expires 2032-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024.

F3 · derivative.exercise_date: The stock option vested as to 25% of the underlying shares on July 12, 2022, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.

Read SEC document
August 12, 2025 Filed Aug 14, 2025 22:02 UTC
Rodman David MalcomChief Medical Officer
Exercise / conversionCommon Stock 6,349 $1.08 $6,856.92
Disclosure

SEC source: 0001933414-25-000093 · wk-form4_1755208973.xml · nonDerivative · entry 1

Rodman David Malcom · CIK 0001672659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 104,256

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 25, 2024.

Read SEC document
July 30, 2025 Filed Jul 30, 2025 20:12 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 8,425 $15.10 $127,203.18
Disclosure

SEC source: 0001933414-25-000081 · wk-form4_1753920718.xml · nonDerivative · entry 4

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 132,934

F4 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.063 to $15.130. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.

Read SEC document
July 30, 2025 Filed Jul 30, 2025 20:12 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 51,500 $14.70 $757,168.45
Disclosure

SEC source: 0001933414-25-000081 · wk-form4_1753920718.xml · nonDerivative · entry 3

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,359

F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.06 to $15.06. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Read SEC document
July 29, 2025 Filed Jul 30, 2025 20:12 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 807 $14.00 $11,301.87
Disclosure

SEC source: 0001933414-25-000081 · wk-form4_1753920718.xml · nonDerivative · entry 2

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,859

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.01. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Read SEC document
July 28, 2025 Filed Jul 30, 2025 20:12 UTC
Levy Adam ScottCFO and Secretary
SaleCommon Stock 12,946 $14.04 $181,803.27
Disclosure

SEC source: 0001933414-25-000081 · wk-form4_1753920718.xml · nonDerivative · entry 1

Levy Adam Scott · CIK 0001693134 · CFO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 193,666

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.20. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.